$BDRL
BLONDER TONGUE LABORATORIES INC

2015 Q1 Form 10-Q Financial Statement

#000114420415031250 Filed on May 15, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $4.742M $5.580M
YoY Change -15.02% -16.95%
Cost Of Revenue $3.362M $3.820M
YoY Change -11.99% -9.69%
Gross Profit $1.380M $1.757M
YoY Change -21.46% -29.44%
Gross Profit Margin 29.1% 31.49%
Selling, General & Admin $1.899M $2.030M
YoY Change -6.45% -0.78%
% of Gross Profit 137.61% 115.54%
Research & Development $804.0K $840.0K
YoY Change -4.29% -1.75%
% of Gross Profit 58.26% 47.81%
Depreciation & Amortization $121.0K $110.0K
YoY Change 10.0% -67.65%
% of Gross Profit 8.77% 6.26%
Operating Expenses $2.703M $2.870M
YoY Change -5.82% -1.07%
Operating Profit -$1.323M -$1.113M
YoY Change 18.87% 169.49%
Interest Expense $0.00 $48.00K
YoY Change -100.0% -30.43%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.415M -$1.161M
YoY Change 21.88% 140.87%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.415M -$1.161M
YoY Change 21.88% 140.87%
Net Earnings / Revenue -29.84% -20.81%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.23 -$0.19
COMMON SHARES
Basic Shares Outstanding 6.263M shares 6.216M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.00K $110.0K
YoY Change -18.18% 37.5%
Cash & Equivalents $94.00K $113.0K
Short-Term Investments
Other Short-Term Assets $930.0K $1.040M
YoY Change -10.58% 11.83%
Inventory $9.310M $8.688M
Prepaid Expenses
Receivables $2.360M $2.415M
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.69M $12.26M
YoY Change 3.53% -18.5%
LONG-TERM ASSETS
Property, Plant & Equipment $3.930M $3.629M
YoY Change 8.29% -7.89%
Goodwill $493.0K
YoY Change
Intangibles $810.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.050M $150.0K
YoY Change 1266.67% -94.21%
Total Long-Term Assets $8.870M $9.253M
YoY Change -4.14% -7.47%
TOTAL ASSETS
Total Short-Term Assets $12.69M $12.26M
Total Long-Term Assets $8.870M $9.253M
Total Assets $21.56M $21.51M
YoY Change 0.23% -14.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.370M $1.397M
YoY Change 69.65% 15.45%
Accrued Expenses $1.170M $750.0K
YoY Change 56.0% -48.28%
Deferred Revenue
YoY Change
Short-Term Debt $1.700M $1.250M
YoY Change 36.0% -28.57%
Long-Term Debt Due $3.800M $4.000M
YoY Change -5.0% 1328.57%
Total Short-Term Liabilities $9.060M $7.421M
YoY Change 22.09% 57.89%
LONG-TERM LIABILITIES
Long-Term Debt $30.00K $93.00K
YoY Change -67.74% -97.73%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $30.00K $93.00K
YoY Change -67.74% -97.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.060M $7.421M
Total Long-Term Liabilities $30.00K $93.00K
Total Liabilities $9.180M $7.514M
YoY Change 22.17% -14.81%
SHAREHOLDERS EQUITY
Retained Earnings -$5.511M -$4.355M
YoY Change 26.54%
Common Stock $26.50M $26.26M
YoY Change 0.9%
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.255M $7.308M
YoY Change -0.73%
Treasury Stock Shares 2.202M shares 2.248M shares
Shareholders Equity $12.38M $13.93M
YoY Change
Total Liabilities & Shareholders Equity $21.56M $21.51M
YoY Change 0.23% -14.1%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$1.415M -$1.161M
YoY Change 21.88% 140.87%
Depreciation, Depletion And Amortization $121.0K $110.0K
YoY Change 10.0% -67.65%
Cash From Operating Activities -$360.0K $390.0K
YoY Change -192.31% -4.88%
INVESTING ACTIVITIES
Capital Expenditures $132.0K $29.00K
YoY Change 355.17% -86.82%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$130.0K -$240.0K
YoY Change -45.83% 9.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $69.00K $70.00K
YoY Change -1.43% 0.0%
Cash From Financing Activities 360.0K -100.0K
YoY Change -460.0% -82.46%
NET CHANGE
Cash From Operating Activities -360.0K 390.0K
Cash From Investing Activities -130.0K -240.0K
Cash From Financing Activities 360.0K -100.0K
Net Change In Cash -130.0K 50.00K
YoY Change -360.0% -113.16%
FREE CASH FLOW
Cash From Operating Activities -$360.0K $390.0K
Capital Expenditures $132.0K $29.00K
Free Cash Flow -$492.0K $361.0K
YoY Change -236.29% 90.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
57000 USD
CY2015Q1 us-gaap Inventory Write Down
InventoryWriteDown
31000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-69000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
451000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
278000 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
30000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1317000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-362000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
132000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-244000 USD
CY2015Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
217000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
26492000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
26435000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5511000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4096000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1354000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1354000 USD
CY2015Q1 us-gaap Treasury Stock Value
TreasuryStockValue
7255000 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
7255000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
12380000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
13738000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21560000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21244000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
176000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
176000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-138000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113000 USD
CY2014Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
70000 USD
CY2014Q1 us-gaap Depreciation
Depreciation
110000 USD
CY2015Q1 us-gaap Depreciation
Depreciation
121000 USD
CY2014Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
261000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
66000 USD
CY2014Q1 us-gaap Inventory Write Down
InventoryWriteDown
83000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-872000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-300000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
385000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-95000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
46000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67000 USD
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8465000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8465000 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2202000 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2202000 shares
CY2014Q1 us-gaap Gross Profit
GrossProfit
1757000 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
1380000 USD
CY2014Q1 us-gaap Selling Expense
SellingExpense
812000 USD
CY2015Q1 us-gaap Selling Expense
SellingExpense
843000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1218000 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1056000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
840000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
804000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
2870000 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
2703000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1113000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1323000 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
48000 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
92000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1161000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1415000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-1161000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-1415000 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6216000 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6263000 shares
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
168000 USD
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
59000 USD
CY2014Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
215000 USD
CY2015Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-133000 USD
CY2015Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
69000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
357000 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
56000 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
66000 USD
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
5341000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5151000 USD
CY2015Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2675000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3045000 USD
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6109000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5487000 USD
CY2015Q1 us-gaap Inventory Gross
InventoryGross
14125000 USD
CY2014Q4 us-gaap Inventory Gross
InventoryGross
13683000 USD
CY2015Q1 bdr Inventory Value Before Reserves
InventoryValueBeforeReserves
4815000 USD
CY2014Q4 bdr Inventory Value Before Reserves
InventoryValueBeforeReserves
4426000 USD
CY2015Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
2820000 USD
CY2014Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
2798000 USD
CY2014Q2 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
25% effective on or about June 27, 2014
CY2015Q1 us-gaap Line Of Credit Facility Periodic Payment Principal
LineOfCreditFacilityPeriodicPaymentPrincipal
18000 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-25000 USD
CY2015Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
426000 USD
CY2008Q3 us-gaap Line Of Credit Facility Increase Decrease Other Net
LineOfCreditFacilityIncreaseDecreaseOtherNet
8783000 USD
CY2015Q1 bdr Line Of Credit Facility Interest Rate Period At One Month
LineOfCreditFacilityInterestRatePeriodAtOneMonth
0.0017 pure
CY2015Q1 bdr Line Of Credit Facility Interest Rate Period At Three Months
LineOfCreditFacilityInterestRatePeriodAtThreeMonths
0.0025 pure
CY2015Q1 bdr Line Of Credit Facility Interest Rate Period At Six Months
LineOfCreditFacilityInterestRatePeriodAtSixMonths
0.0036 pure
CY2014 bdr Amendment Fee
AmendmentFee
45000 USD
CY2015Q1 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.0325 pure
CY2014Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
46000 USD
CY2015Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
0 USD
CY2015Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
1121000 USD
CY2015Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2016-02-01
CY2015Q1 us-gaap Inventory Related Text
InventoryRelatedText
Inventories are stated at the lower of cost, determined by the first-in, first-out (“FIFO”) method, or market.
CY2015Q1 bdr Expected Decrease In Annual Expenses
ExpectedDecreaseInAnnualExpenses
2100000 USD

Files In Submission

Name View Source Status
0001144204-15-031250-index-headers.html Edgar Link pending
0001144204-15-031250-index.html Edgar Link pending
0001144204-15-031250.txt Edgar Link pending
0001144204-15-031250-xbrl.zip Edgar Link pending
bdr-20150331.xml Edgar Link completed
bdr-20150331.xsd Edgar Link pending
bdr-20150331_cal.xml Edgar Link unprocessable
bdr-20150331_def.xml Edgar Link unprocessable
bdr-20150331_lab.xml Edgar Link unprocessable
bdr-20150331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tex10-4logo.jpg Edgar Link pending
v409395_10q.htm Edgar Link pending
v409395_ex10-4.htm Edgar Link pending
v409395_ex10-5.htm Edgar Link pending
v409395_ex31-1.htm Edgar Link pending
v409395_ex31-2.htm Edgar Link pending
v409395_ex32-1.htm Edgar Link pending